Evidence map›Paper›PMID 36732817›Full record

ArticleBiomedical engineering online2023

Computer-aided diagnosis of primary membranous nephropathy using expert system.

Jie Gao, Siyang Wang, Liang Xu, Jinyan Wang, Jiao Guo, Haiping Wang, Jing Sun

Open access · goldAbstract read
In one paragraph

Article in Biomedical engineering online, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jie GaoDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Siyang Wang953th Hospital, Shigatse Branch, Army Medical University (Third Military Medical University), Shigatse, China.
Liang XuDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Jinyan WangDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Jiao GuoDepartment of Scientific Research, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Haiping WangDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China. cktwhpvvv@163.com.
Jing SunDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China. sunj5708@126.com.
Shandong Provincial Hospital · CNArmy Medical University · CNShandong First Medical University · CN

Funding

Shandong Medical and Health Science and Technology Development Plan 202103050761
6 · The paper itself

Abstract

backgroundThe diagnosis of primary membranous nephropathy (PMN) often depends on invasive renal biopsy, and the diagnosis based on clinical manifestations and target antigens may not be completely reliable as it could be affected by uncertain factors. Moreover, different experts could even have different diagnosis results due to their different experiences, which could further impact the reliability of the diagnosis. Therefore, how to properly integrate the knowledge of different experts to provide more reliable and comprehensive PMN diagnosis has become an urgent issue.

methodsThis paper develops a belief rule-based system for PMN diagnosis. The belief rule base is constructed based on the knowledge of the experts, with 9 biochemical indicators selected as the input variables. The belief rule-based system is developed of three layers: (1) input layer; (2) belief rule base layer; and (3) output layer, where 9 biochemical indicators are selected as the input variables and the diagnosis result is provided as the conclusion. The belief rule base layer is constructed based on the knowledge of the experts. The final validation was held with gold pattern clinical cases, i.e., with known and clinically confirmed diagnoses.

results134 patients are used in this study, and the proposed method is defined by its sensitivity, specificity, accuracy and area under curve (AUC), which are 98.0%, 96.9%, 97.8% and 0.93, respectively. The results of this study present a novel and effective way for PMN diagnosis without the requirement of renal biopsy.

conclusionsThrough analysis of the diagnosis results and comparisons with other methods, it can be concluded that the developed system could help diagnose PMN based on biochemical indicators with relatively high accuracy.

Indexed as

Glomerulonephritis, MembranousComputersExpert SystemsHumansReceptors, Phospholipase A2Reproducibility of ResultsReceptors, Phospholipase A2Belief rule-based systemExpert systemMembranous nephropathyPrimary membranous nephropathy

Identifiers

PMID36732817
PMCPMC9893592
OpenAlexW4319032165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.